["{\n\"step_by_step_thinking\": \"The question is about primary progressive multiple sclerosis. The relevant documents don't mention ocrelizumab or any specific treatment for primary progressive multiple sclerosis. However, one of the documents discusses early prognostic factors for disability in multiple sclerosis and mentions that high age at onset was associated with a primary progressive course. Another document explores the association between low arylsulfatase A genotypes (ASAp/ASAp and ASA-/ASAp) and multiple sclerosis. None of these findings suggest that ocrelizumab is effective for primary progressive multiple sclerosis.\",\n\"answer_choice\": \"B: no\"\n}"]